North America Research Institute | NARI San Dimas, CA - Other PI's

Research site

Location

1335 W. Cypress Street Suite 204, San Dimas, California, United States of America

Site insights

Top conditions

Top treatments

Clazakizumab

Apricoxib

Lanthanum Carbonate

Gemcitabine

Calcifediol

Capecitabine

Vicadrostat

SNF472

MK-2060

Evinacumab

Parent organization

This site is a part of North America Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Molly Way

Verified by this site

Active trials

6 of 19 total trials

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of this study is t...

Enrolling

Focal Segmental Glomerulosclerosis

Drug: Placebo

Drug: BI 764198

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific type of medication...

Active, not recruiting

Chronic Kidney Disease

Drug: Vicadrostat

Drug: Empagliflozin

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a do...

Enrolling

Atherosclerotic Cardiovascular Disease

Atherosclerotic Cardiovascular Disease in Patients With ESKD

Drug: Placebo

Drug: CSL300

Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants

The purpose of this study is to evaluate the safety and efficacy of the Moda-flx Hemodialysis System™ when used Under Professional Care Settings by t...

Enrolling

End Stage Kidney Disease

Device: Moda-flx Hemodialysis System™

Locations recently updated

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease (ANCHOR-POC)

This study is researching experimental drugs called ALN-ANG3 and evinacumab (called "study drugs"). The study is focused on participants who have dia...

Enrolling

Diabetic Kidney Disease (DKD)

Drug: Evinacumab

Drug: ALN-ANG3 placebo

VE303 for Prevention of Recurrent Clostridioides Difficile Infection (RESTORATiVE303)

The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week...

Enrolling

CDI

C.Difficile Diarrhea

Biological: Placebo

Biological: VE303